Greenbrook TMS (TSX:GTMS) ROCE % : 0.00% (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Greenbrook TMS's annualized ROCE % for the quarter that ended in Sep. 2023 was 0.00%.

Greenbrook TMS ROCE % Historical Data

The historical data trend for Greenbrook TMS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS ROCE % Chart

Greenbrook TMS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-65.18

-47.64

-64.22

-42.28

-93.97

Greenbrook TMS Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-83.20	-130.21	-35.93	-	-

Greenbrook TMS ROCE % Calculation

Greenbrook TMS's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-72.951	/	( ( (92.984 - 23.713)	+	(136.456 - 50.464) )	/ 2 )
	=	-72.951	/	( (69.271	+	85.992)	/ 2 )
	=	-72.951	/	77.6315
	=	-93.97 %

Greenbrook TMS's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-47.384	/	( ( (0 - 0)	+	(0 - 0) )	/ 1 )
	=	-47.384	/	( ( 0	+	0 )	/ 1 )
	=	-47.384	/	0
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Greenbrook TMS (TSX:GTMS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Greenbrook TMS ROCE % Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenbrook TMS (TSX:GTMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (TSX:GTMS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GBNH:USA

Address

890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4

Website

https://www.greenbrooktms.com

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Greenbrook TMS (TSX:GTMS) Headlines

No Headlines